DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,540,000 | +12.4% | 1,500,000 | +200.0% | 0.02% | +11.1% |
| Q2 2023 | $3,150,000 | -12.9% | 500,000 | -20.2% | 0.02% | -10.0% |
| Q1 2023 | $3,617,121 | -49.1% | 626,884 | -9.4% | 0.02% | -53.5% |
| Q4 2022 | $7,101,264 | -70.4% | 692,131 | -51.8% | 0.04% | -72.6% |
| Q3 2022 | $24,021,000 | +19.4% | 1,436,636 | 0.0% | 0.16% | +37.7% |
| Q2 2022 | $20,113,000 | -13.3% | 1,436,636 | 0.0% | 0.11% | -14.3% |
| Q1 2022 | $23,202,000 | -24.6% | 1,436,636 | 0.0% | 0.13% | -11.3% |
| Q4 2021 | $30,758,000 | +45.7% | 1,436,636 | 0.0% | 0.15% | +61.3% |
| Q3 2021 | $21,104,000 | -26.1% | 1,436,636 | 0.0% | 0.09% | -25.6% |
| Q2 2021 | $28,575,000 | -33.5% | 1,436,636 | 0.0% | 0.12% | -32.8% |
| Q1 2021 | $42,955,000 | – | 1,436,636 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |